Prostate Cancer

Prostate cancer advocacy groups work to change therapy approval process

Published in Cancer Weekly, July 13th, 2004

For the first time, the four major prostate cancer advocacy groups are combining forces with the common goal of working with the U.S. Food and Drug Administration (FDA) to streamline the approval process for critical prostate cancer treatments by changing the traditional measures of a research study's success or failure, known as clinical trial endpoints, without compromising safety.

The four prostate cancer advocacy groups are the Prostate Cancer Education Council, National Prostate Cancer Coalition, Prostate Cancer Foundation, and Us TOO International Prostate Cancer Education and Support Network.

"Prostate cancer is the most common non-skin cancer...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-07-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry